To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Israel, MD
Valeant Pharmaceuticals North America LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsd Moores Cancer Center
La Jolla, California, United States
- Sharp Clinical Oncology Research
San Diego, California, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Indiana University
Indianapolis, Indiana, United States
- Columbia University Medical Center
New York, New York, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Kaiser Permanente
Portland, Oregon, United States
- Northwest Cancer Specialists
Portland, Oregon, United States
- Providence Medical Center
Portland, Oregon, United States
- Urology of Virginia, Sentara Medical Group
Norfolk, Virginia, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Virginia Mason Medical Center Urology and Renal Transplantation
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2008
- Primary completion
- 30 Apr 2012
- Completion
- 31 May 2015
- Last update posted
- 23 May 2017
- Registered enrollment
- 122
- Registry id
- NCT00715078
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.